Pepumi is a community for thoughtful discussion of GLP-1s, peptide research, laboratory evidence and everyday experiences. These guidelines explain how to make a useful contribution and what members can expect from one another.
1. Make room for people with different experience
Beginners and experienced members should both be able to ask questions. Explain unfamiliar terms, respond to the question that was asked and challenge claims through evidence. Insults, harassment, body shaming, threats and hostility based on someone’s background do not belong here.
No member has to disclose a diagnosis, weight, photograph or personal history to earn a respectful response. A different experience is not, by itself, a reason to accuse someone of dishonesty.
2. Label evidence and experience clearly
Say whether a claim comes from a personal observation, a laboratory analysis, a cell or animal experiment, a human study, or a hypothesis. Link the original source and include its date when discussing research. Identify press releases, preprints and trial registrations instead of presenting them as completed peer-reviewed results.
When sharing a paper, explain the population or model, the measured outcome and the limitation relevant to your argument. Do not fabricate citations, results, reviews or personal experiences. AI-assisted summaries must be checked against their sources; plausible wording is not evidence.
The myPeptides monograph register is a starting point for background and references. Follow the primary reference when a particular result is central to a discussion.
3. Discuss health responsibly
Personal experiences, including disappointing results and side effects, are welcome. Give useful context without turning your experience into a prescription for someone else. Members and moderators cannot diagnose an individual through forum posts.
Do not pressure another person to start, stop or change a treatment, or dismiss concerning symptoms because you had a different experience. Individual decisions belong with a qualified clinician or pharmacist. Seek appropriate medical help for urgent or rapidly worsening symptoms instead of waiting for a forum reply.
4. Name substances and blends precisely
Write out a compound’s full name when an abbreviation could be misunderstood. For a blend, list every component and the composition stated on the label. Separate evidence about each component from evidence about the combination.
For example, CagriSema means cagrilintide + semaglutide. In our Loretta section, Loretta means Eloralintide (Elora) + Retatrutide (Reta), labelled 10 / 2.5, in that component order. Include the actual units when describing a particular product. A blend composition is not an individual dose or an administration schedule, and a familiar name does not prove that two products are identical.
5. Make CoA discussions traceable
For a laboratory report, give the supplier, compound, batch, laboratory, report number and test date where available. Link the exact CoA library entry so others can inspect the original report and its archive.
Distinguish identity, purity, measured content, sterility and other tests. Quote what was actually measured and identify what was not tested. A result describes the submitted sample and method; it does not certify every vial from a supplier. An archived document or directory listing is not a Pepumi endorsement.
If you suspect a mismatch or misleading claim, describe it factually and show the relevant documents. Do not alter a report or crop away information that changes how its result should be understood.
6. Be transparent about commercial interests
Disclose supplier relationships, sponsorship, affiliate links, free samples and other interests when they are relevant to a post. A factual link that helps assess a report is different from repeatedly promoting a business.
Keep supplier records in the supplier directory and evidence discussions in the appropriate forum. Undisclosed advertising, fabricated reviews, referral-code spam and unsolicited sales messages are not welcome. Do not use discussions or private messages to pressure members into purchases or payments. Pepumi’s discussion areas are not a member-to-member sales board.
7. Protect privacy before posting
Treat public topics as material that can be read, indexed, copied and shared beyond the forum. Use a pseudonym if you prefer. Never publish another person’s address, contact details, identifying health information or private correspondence without permission.
Remove visible names, faces, addresses, order numbers and other identifying details from images and documents before uploading them. Metadata cleaning does not remove text printed on a label or information visible in a photograph. Do not post passwords, API keys, login codes or private access links. Share only information you are comfortable making public.
8. Put useful conversations in the right place
Search before starting a duplicate topic and choose the most specific category. Introduce yourself in Introduction, ask basic questions in Beginner questions, and use the dedicated compound, testing or regional sections for their subjects.
Give topics descriptive titles, keep replies relevant and add substantive updates to an existing discussion when appropriate. The category introduction posts and this guidelines topic are closed reference pages; create a new topic for your own question or introduction. Ordinary discussion topics remain open to replies unless staff close them.
9. Respect language, sources and other people’s work
Use the language and regional sections to make local context clear. Include the country and source date for claims that depend on location. Keep substance names, batch codes and units accurate when translating.
Quote only what is needed to discuss a source, link the original and add your own explanation. Do not republish entire paid articles, private reports or other people’s work without the right to do so. Correct substantive errors openly and leave enough context for earlier replies to remain understandable.
10. Report problems and help us improve
Use the flag function for spam, harassment, privacy problems or misleading content that needs staff review. Explain the issue briefly and point to the relevant evidence. Do not organise pile-ons or repeat sensitive information in a public complaint.
Staff may clarify, move, edit, restrict or remove content and limit accounts when necessary to maintain these standards. If you disagree with a decision, contact staff calmly with the relevant topic link and context. Suggestions about the rules or the site belong in Site feedback.
These guidelines will develop with the community. The aim is a forum where questions are welcome, evidence can be examined and members can share experiences without pressure or personal attacks.